Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis.

× No keyword cloud information.

6 in total

1. Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.

Authors: Lorena Baietto; Antonio D'Avolio; Francesco Giuseppe De Rosa; Silvia Garazzino; Marianna Michelazzo; Giusi Ventimiglia; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Journal: Anal Bioanal Chem Date: 2009-11-09 Impact factor: 4.142

2. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.

Authors: Nimish Patel; Katie Cardone; Darren W Grabe; Shari Meola; Christopher Hoy; Harold Manley; George L Drusano; Thomas P Lodise
Journal: Antimicrob Agents Chemother Date: 2011-01-31 Impact factor: 5.191

3. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

Authors: Sujata M Bhavnani; Christopher M Rubino; Paul G Ambrose; George L Drusano
Journal: Clin Infect Dis Date: 2010-06-15 Impact factor: 9.079

1 in total

Review 1. Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors: Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal: Clin Microbiol Rev Date: 2016-07 Impact factor: 26.132

1 in total

Pharmacokinetics of daptomycin in a patient with severe renal failure not receiving dialysis.

1. Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.

2. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.

3. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

4. Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application.

5. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis.

6. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers.

Review 1. Inhaled Antibiotics for Gram-Negative Respiratory Infections.